The South Africa animal health market size was estimated at USD 958.47 million in 2024 and is projected to reach USD 1.80 billion by 2033, growing at a CAGR of 7.4% from 2025 to 2033. The market is continuously growing driven by rising awareness of zoonotic and emerging diseases, increasing aquaculture and poultry production and government regulations and disease control programs.
Global health concerns, such as COVID-19, highlighted the importance of controlling zoonotic diseases. South Africa, with its diverse wildlife and livestock populations, faces unique risks of disease spillovers. Zoonotic diseases, account for over 60% of all recognized human illnesses and nearly 75% of emerging infectious diseases (EIDs). In developing countries such as South Africa, EIDs carry a mortality rate of 47.3%, posing a serious public health challenge. Majority of these emerging infections (71.8%) originate from wildlife, underscoring the critical need for strengthened surveillance, early detection, and One Health approaches that integrate animal, human, and environmental health strategies.
South Africa is witnessing growth in the aquaculture and poultry industries, driven by rising demand for affordable animal protein. According to U.S. Department of Agriculture (USDA) report of September 2024, South Africa’s chicken meat production is expected to rise 3% to 1.65 million tons in 2025, driven by industry recovery post-HPAI. Consumption is set to grow 2% to 1.88 million tons, supported by easing food inflation. Poultry and aquaculture face high disease risks, including bacterial, viral, and parasitic infections that can devastate production. Farmers invest in vaccines, feed supplements, water treatments, and biosecurity solutions to maintain yields and profitability. Poultry, being the largest protein source, demands continuous innovation in health management, while aquaculture expansion brings new opportunities for specialized veterinary pharmaceuticals. This diversification of animal farming strengthens the market for veterinary medicines, diagnostics, and nutritional products, positioning aquaculture and poultry health as important growth drivers.
Government-led programs targeting zoonotic diseases, foot-and-mouth disease (FMD), and avian influenza are major growth drivers. Regulatory authorities like the Department of Agriculture, Land Reform, and Rural Development (DALRRD) work with veterinary organizations to strengthen surveillance, vaccination campaigns, and biosecurity frameworks. Policies supporting antimicrobial stewardship and responsible veterinary drug usage are improving product adoption while promoting safer animal-derived food supply chains. Moreover, ongoing trade negotiations push farmers to meet international animal health standards, creating demand for certified vaccines and medicines. This regulatory environment strengthens trust in veterinary products, accelerates adoption, and fosters growth in the South African market.
This product will be delivered within 1-3 business days.
Global health concerns, such as COVID-19, highlighted the importance of controlling zoonotic diseases. South Africa, with its diverse wildlife and livestock populations, faces unique risks of disease spillovers. Zoonotic diseases, account for over 60% of all recognized human illnesses and nearly 75% of emerging infectious diseases (EIDs). In developing countries such as South Africa, EIDs carry a mortality rate of 47.3%, posing a serious public health challenge. Majority of these emerging infections (71.8%) originate from wildlife, underscoring the critical need for strengthened surveillance, early detection, and One Health approaches that integrate animal, human, and environmental health strategies.
South Africa is witnessing growth in the aquaculture and poultry industries, driven by rising demand for affordable animal protein. According to U.S. Department of Agriculture (USDA) report of September 2024, South Africa’s chicken meat production is expected to rise 3% to 1.65 million tons in 2025, driven by industry recovery post-HPAI. Consumption is set to grow 2% to 1.88 million tons, supported by easing food inflation. Poultry and aquaculture face high disease risks, including bacterial, viral, and parasitic infections that can devastate production. Farmers invest in vaccines, feed supplements, water treatments, and biosecurity solutions to maintain yields and profitability. Poultry, being the largest protein source, demands continuous innovation in health management, while aquaculture expansion brings new opportunities for specialized veterinary pharmaceuticals. This diversification of animal farming strengthens the market for veterinary medicines, diagnostics, and nutritional products, positioning aquaculture and poultry health as important growth drivers.
Government-led programs targeting zoonotic diseases, foot-and-mouth disease (FMD), and avian influenza are major growth drivers. Regulatory authorities like the Department of Agriculture, Land Reform, and Rural Development (DALRRD) work with veterinary organizations to strengthen surveillance, vaccination campaigns, and biosecurity frameworks. Policies supporting antimicrobial stewardship and responsible veterinary drug usage are improving product adoption while promoting safer animal-derived food supply chains. Moreover, ongoing trade negotiations push farmers to meet international animal health standards, creating demand for certified vaccines and medicines. This regulatory environment strengthens trust in veterinary products, accelerates adoption, and fosters growth in the South African market.
South Africa Animal Health Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the South Africa Animal Health market report based on product, animal, disease, distribution channel, and end use.Animal Outlook (Revenue, USD Million, 2021-2033)
- Production Animals
- Poultry
- Swine
- Cattle
- Sheep & Goats
- Fish
- Companion Animals
- Dogs
- Cats
- Horses
- Pet Birds
- Others
Product Outlook (Revenue, USD Million, 2021-2033)
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Medicated Feed Additives
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
Disease Outlook (Revenue, USD Million, 2021-2033)
- Poultry Diseases
- Avian Influenza
- Salmonellosis
- Coccidiosis
- Infectious Bronchitis
- Others
- Swine Diseases
- Porcine Reproductive and Respiratory Syndrome (PRRS)
- African Swine Fever
- Salmonellosis
- Porcine Circovirus (PCV)
- Others
- Cattle Diseases
- Bovine Respiratory Disease (BRD)
- Mastitis
- Foot and Mouth Disease (FMD)
- Bovine Viral Diarrhoea (BVD)
- Others
- Sheep & Goat Diseases
- Bacterial Diseases
- Parasitic Diseases
- Viral Diseases
- Others
- Fish/Aquaculture Diseases
- Bacterial Diseases
- Parasitic Diseases
- Others
- Canine Diseases
- Gastrointestinal
- Neurological
- Ophthalmic
- Others
- Feline Diseases
- Gastrointestinal
- Neurological
- Ophthalmic
- Others
- Equine Diseases
- Gastrointestinal
- Neurological
- Ophthalmic
- Others
- Pet Bird Diseases
- Gastrointestinal
- Ophthalmic
- Others
- Other Companion Animal Diseases
- Gastrointestinal
- Ophthalmic
- Others
Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Retail
- E-Commerce
- Hospital/ Clinic Pharmacy
End Use Outlook (Revenue, USD Million, 2021-2033)
- Veterinary Reference Laboratories
- Point-of-care Testing/In-house Testing
- Veterinary Hospitals & Clinics
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. South Africa Animal Health Market Variable Trends & Scope
Chapter 4. South Africa Animal Health Market: Animal Estimates & Trend Analysis
Chapter 5. South Africa Animal Health Market: Product Estimates & Trend Analysis
Chapter 6. South Africa Animal Health Market: by Disease Estimates & Trend Analysis
Chapter 7. South Africa Animal Health Market: Distribution Channel Estimates & Trend Analysis
Chapter 8. South Africa Animal Health Market: Distribution Channel Estimates & Trend Analysis
Chapter 9. South Africa Animal Health Market: by End Use Estimates & Trend Analysis
Chapter 10. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this South Africa Animal Health market report include:- Boehringer Ingelheim International GmbH
- Zoetis Services LLC
- Merck & Co., Inc.
- Elanco
- Virbac
- Ceva Santé Animale
- Dechra
- Phibro Animal Health Corporation
- Bimeda Corporate (Afrivet)
- Bupo Animal Health (Pty) Ltd
- Vetoquinol
- IDEXX
- Avimune Inc.
- Afrigen Biologics and Vaccines
- Deltamune
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 150 |
Published | August 2025 |
Forecast Period | 2024 - 2033 |
Estimated Market Value ( USD | $ 958.47 Million |
Forecasted Market Value ( USD | $ 1800 Million |
Compound Annual Growth Rate | 7.4% |
Regions Covered | South Africa |
No. of Companies Mentioned | 16 |